Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Curcumin is a potent antitumor agent. The objective of this study was to explore the interaction between curcumin and PGK1, an oncogene in the FOXD3/miR-143 axis, in prostate cancer therapy.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Cancer Chemother. Pharmacol.

Title: Cancer chemotherapy and pharmacology

Publisher: Springer Nature

ISSN (Electronic): 1432-0843

ISSN (Print): 0344-5704

Publication date (Electronic): May 2017

Volume: 79

Issue: 5

Affiliations

[1 ] Surgical Department I (Urology Department), Shanghai University of Traditional Chinese Medicine Affiliated LONGHUA Hospital, No. 725 Wanping Road South, Xuhui District, Shanghai, 200032, China.

[2 ] Oncology Department of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine Affiliated PUTUO Hospital, No. 164 Lanxi Road, Putuo District, Shanghai, 200062, China.

[3 ] Surgical Department I (Urology Department), Shanghai University of Traditional Chinese Medicine Affiliated LONGHUA Hospital, No. 725 Wanping Road South, Xuhui District, Shanghai, 200032, China. chenleijoe@126.com.

[4 ] Oncology Department of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine Affiliated PUTUO Hospital, No. 164 Lanxi Road, Putuo District, Shanghai, 200062, China. liangfang9876@126.com.

Article

Publisher Item ID: 10.1007/s00280-017-3301-1

DOI: 10.1007/s00280-017-3301-1

PubMed ID: 28391351

SO-VID: 4a2faece-71d2-4850-b1d4-6e3fc23d171a

History

Keywords: Curcumin,FOXD3/miR-143,PGK1,Prostate cancer

Data availability:

Keywords: Curcumin, FOXD3/miR-143, PGK1, Prostate cancer

Comments

Comment on this article

scite_

Cited by 21

See all cited by